Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
1993 2
1994 5
1995 3
1996 6
1997 4
1998 2
1999 3
2000 1
2001 4
2002 2
2003 5
2004 6
2005 5
2006 6
2007 5
2008 8
2009 3
2010 2
2011 3
2012 9
2013 5
2014 1
2015 2
2016 3
2017 1
2018 2
2019 5
2020 6
2021 1
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

104 results

Results by year

Filters applied: . Clear all
Page 1
AXL inhibition improves BRAF-targeted treatment in melanoma.
Nyakas M, Fleten KG, Haugen MH, Engedal N, Sveen C, Farstad IN, Flørenes VA, Prasmickaite L, Mælandsmo GM, Seip K. Nyakas M, et al. Among authors: florenes va. Sci Rep. 2022 Mar 24;12(1):5076. doi: 10.1038/s41598-022-09078-z. Sci Rep. 2022. PMID: 35332208 Free PMC article.
Targeting Telomerase with an HLA Class II-Restricted TCR for Cancer Immunotherapy.
Dillard P, Köksal H, Maggadottir SM, Winge-Main A, Pollmann S, Menard M, Myhre MR, Mælandsmo GM, Flørenes VA, Gaudernack G, Kvalheim G, Wälchli S, Inderberg EM. Dillard P, et al. Among authors: florenes va. Mol Ther. 2021 Mar 3;29(3):1199-1213. doi: 10.1016/j.ymthe.2020.11.019. Epub 2020 Nov 17. Mol Ther. 2021. PMID: 33212301 Free PMC article.
Soluble AXL is ubiquitously present in malignant serous effusions.
Flem Karlsen K, McFadden E, Flørenes VA, Davidson B. Flem Karlsen K, et al. Among authors: florenes va. Gynecol Oncol. 2019 Feb;152(2):408-415. doi: 10.1016/j.ygyno.2018.11.012. Epub 2018 Nov 15. Gynecol Oncol. 2019. PMID: 30448261
Soluble AXL as a marker of disease progression and survival in melanoma.
Flem-Karlsen K, Nyakas M, Farstad IN, McFadden E, Wernhoff P, Jacobsen KD, Flørenes VA, Mælandsmo GM. Flem-Karlsen K, et al. Among authors: florenes va. PLoS One. 2020 Jan 9;15(1):e0227187. doi: 10.1371/journal.pone.0227187. eCollection 2020. PLoS One. 2020. PMID: 31917795 Free PMC article.
MX 2 is a novel regulator of cell cycle in melanoma cells.
Juraleviciute M, Pozniak J, Nsengimana J, Harland M, Randerson-Moor J, Wernhoff P, Bassarova A, Øy GF, Trøen G, Flørenes VA, Bishop DT, Herlyn M, Newton-Bishop J, Slipicevic A. Juraleviciute M, et al. Among authors: florenes va. Pigment Cell Melanoma Res. 2020 May;33(3):446-457. doi: 10.1111/pcmr.12837. Epub 2019 Nov 13. Pigment Cell Melanoma Res. 2020. PMID: 31660681 Free PMC article.
Pax-5 expression in nonhematopoietic tissues.
Torlakovic E, Slipicevic A, Robinson C, DeCoteau JF, Alfsen GC, Vyberg M, Chibbar R, Flørenes VA. Torlakovic E, et al. Among authors: florenes va. Am J Clin Pathol. 2006 Nov;126(5):798-804. doi: 10.1309/XEC7-JMW9-YRM7-4RNO. Am J Clin Pathol. 2006. PMID: 17050077
Up-regulation of ephrin-A1 during melanoma progression.
Easty DJ, Hill SP, Hsu MY, Fallowfield ME, Florenes VA, Herlyn M, Bennett DC. Easty DJ, et al. Among authors: florenes va. Int J Cancer. 1999 Oct 22;84(5):494-501. doi: 10.1002/(sici)1097-0215(19991022)84:5<494::aid-ijc8>3.0.co;2-o. Int J Cancer. 1999. PMID: 10502726 Free article.
104 results